# Lime Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lime-health

- Industry: Healthcare IT
- Headquarters: St-Augustin-de-Desmaures, Canada
- Website: www.lime.health/
- Total disclosed funding: $2.3M
- Latest round: Seed (Mar 27, 2024)
- Investors on record: 3

## About

Based in Quebec, Canada, and founded by Francis Robichaud (CEO) in 2020, Lime Health Inc. operates as a healthcare IT company offering an end-to-end patient engagement/interaction platform. Some of the firm’s clients include CALIAN, fraserHealth, CRCHUM, MEDTEQ, etc. In March 2024, the firm raised USD 2.25 million in seed funding led by investors Investissement Québec, Desjardins Group, and Third Culture Capital.

Lime Health empowers healthcare teams to engage patients in their care, collaborate effectively, and take prompt action based on real-time metrics. The company offers platforms that integrate with existing information systems, enabling healthcare providers including quality teams, care teams, managers, patient partnership programs, and information and research teams, to automatically collect data and analyze them to measure care quality. The company measures patient experience through PREMs, value-based care, staff experience, patient-reported measurements (PROMs), patient education, and safety of care.  Additionally, the firm, through its platforms, offers automated SMS and email solutions along with security and privacy.

Lime Health plans to utilize the May 2024 funding to encourage its commercial growth throughout the remainder of Canada while keeping up development efforts for its diverse range of products and establishing new business relationships with other significant players in the healthcare technology industry.

## Funding rounds

- Seed, Mar 27, 2024, $2.3M — Investment Quebec, Third Culture Capital, Desjardins Group

## Investors

- Investment Quebec (https://capitalatlas.ai/funds/investment-quebec) — Seed
- Third Culture Capital (https://capitalatlas.ai/funds/third-culture-capital) — Seed
- Desjardins Group — Seed